DLBCL Patient stratification using serum protein profiling
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignancy which poses a challenge for treatment efficiency. To better stratify DLBCL patients and optimize treatment protocols, we analyzed the serum proteome using samples from a population-based cohort of DLBCL patients. Our objective was to find association between serum protein expression with clinical parameters such as overall